Tivol · American journal of medical genetics 1996 · Cross-sectional observational genetic study · n=40

Mutational analysis of the human MAOA gene.

Level 4 - case-series / case-control

Cross-sectional genetic sequencing study in a sample of control individuals.

PubMed 8678123 · doi:10.1002/(SICI)1096-8628(19960216)67:1<92::AID-AJMG16>3.0.CO;2-K · record verified 2026-08-26

What was done

Researchers evaluated the coding sequence of the human MAOA gene in 40 control males displaying a greater than 100-fold variation in MAO-A enzyme activity in cultured skin fibroblasts. Coding variations were screened and identified using reverse transcription-polymerase chain reaction (RT-PCR), single-strand conformation polymorphism (SSCP) analysis, and direct sequencing of mRNA or genomic DNA.

What was found

The MAOA coding region demonstrated high sequence conservation. Only 5 polymorphisms were detected across the 40 subjects. Four of these were in the third codon position and were synonymous (did not alter the amino acid sequence). The single non-synonymous variation resulted in a conservative lysine-to-arginine (Lys -> Arg) substitution that was predicted to be neutral and not affect protein structure.

Why it matters

These findings indicate that large variations in baseline MAO-A enzymatic activity are not caused by structural coding mutations in the MAOA gene, pointing instead toward regulatory or non-coding mechanisms. The study also validated genomic DNA primer sets to enable screening of MAOA mutations in clinical populations with neuropsychiatric conditions.

Limits

The study evaluated a small sample (40 males) and was restricted to control subjects. Analysis was focused on the coding sequence, leaving non-coding regulatory, promoter, and intronic regions unexamined.

Cited by